Beacon Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Beacon Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $0 - $384	5 New	5 $0
Q3 2019 Oct 22, 2019	SELL	$42.77 - $50.71 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $0 - $0	0 New	0 $0
Q1 2019 Apr 08, 2019	BUY	$45.12 - $53.8 $0 - $0	0 New	0 $0
Q4 2018 Jan 23, 2019	BUY	$48.76 - $63.23 $0 - $0	0 New	0 $0
Q3 2018 Oct 16, 2018	BUY	$55.19 - $62.25 $0 - $0	0 New	0 $0
Q2 2018 Jul 16, 2018	SELL	$50.53 - $62.98 $2,577 - $3,211	-51 Closed	0 $0
Q1 2018 Apr 04, 2018	BUY	$59.92 - $68.98 $2,217 - $2,552	37 Added 264.29%	51 $3,000
Q4 2017 Jan 11, 2018	BUY	$59.94 - $65.35 $839 - $914	14	14 $1,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Beacon Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Capital Management, Inc. with notifications on news.